News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,749 Results
Type
Article (42840)
Company Profile (297)
Press Release (681611)
Multimedia
Podcasts (91)
Webinars (15)
Section
Business (210577)
Career Advice (2095)
Deals (36671)
Drug Delivery (107)
Drug Development (83160)
Employer Resources (175)
FDA (16647)
Job Trends (15440)
News (356410)
Policy (33996)
Tag
Academia (2600)
Accelerated approval (10)
Adcomms (23)
Allergies (101)
Alliances (51577)
ALS (112)
Alzheimer's disease (1464)
Antibody-drug conjugate (ADC) (161)
Approvals (16647)
Artificial intelligence (330)
Autoimmune disease (30)
Automation (19)
Bankruptcy (372)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (128)
Biotechnology (188)
Bladder cancer (93)
Brain cancer (38)
Breast cancer (370)
Cancer (2917)
Cardiovascular disease (224)
Career advice (1758)
Career pathing (31)
CAR-T (188)
CDC (32)
Cell therapy (509)
Cervical cancer (22)
Clinical research (68424)
Collaboration (1046)
Company closure (3)
Compensation (695)
Complete response letters (29)
COVID-19 (2697)
CRISPR (62)
C-suite (336)
Cystic fibrosis (116)
Data (3024)
Decentralized trials (2)
Denatured (30)
Depression (64)
Diabetes (350)
Diagnostics (6509)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (143)
Drug pricing (135)
Drug shortages (31)
Duchenne muscular dystrophy (127)
Earnings (89165)
Editorial (42)
Employer branding (21)
Employer resources (151)
Events (116646)
Executive appointments (866)
FDA (18328)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (945)
Gene editing (136)
Generative AI (24)
Gene therapy (391)
GLP-1 (828)
Government (4630)
Grass and pollen (5)
Guidances (181)
Healthcare (19024)
HIV (40)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (158)
Immuno-oncology (9)
Indications (40)
Infectious disease (2870)
Inflammatory bowel disease (153)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (122)
Interviews (323)
IPO (16869)
IRA (51)
Job creations (4064)
Job search strategy (1494)
Kidney cancer (13)
Labor market (52)
Layoffs (518)
Leadership (20)
Legal (8401)
Liver cancer (80)
Longevity (12)
Lung cancer (405)
Lymphoma (211)
Machine learning (11)
Management (59)
Manufacturing (406)
MASH (92)
Medical device (13548)
Medtech (13553)
Mergers & acquisitions (20519)
Metabolic disorders (874)
Multiple sclerosis (97)
NASH (17)
Neurodegenerative disease (118)
Neuropsychiatric disorders (34)
Neuroscience (2163)
NextGen: Class of 2025 (6642)
Non-profit (4536)
Now hiring (47)
Obesity (444)
Opinion (242)
Ovarian cancer (102)
Pain (119)
Pancreatic cancer (121)
Parkinson's disease (188)
Partnered (22)
Patents (305)
Patient recruitment (169)
Peanut (53)
People (59683)
Pharmaceutical (91)
Pharmacy benefit managers (23)
Phase I (21224)
Phase II (30110)
Phase III (22546)
Pipeline (1655)
Policy (215)
Postmarket research (2654)
Preclinical (9058)
Press Release (68)
Prostate cancer (141)
Psychedelics (38)
Radiopharmaceuticals (259)
Rare diseases (480)
Real estate (6268)
Recruiting (68)
Regulatory (23510)
Reports (50)
Research institute (2375)
Resumes & cover letters (359)
Rett syndrome (9)
RNA editing (9)
RSV (49)
Schizophrenia (94)
Series A (161)
Series B (110)
Service/supplier (12)
Sickle cell disease (63)
Special edition (19)
Spinal muscular atrophy (151)
Sponsored (33)
Startups (3739)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (63)
The Weekly (59)
Vaccines (802)
Venture capital (54)
Weight loss (276)
Women's health (47)
Worklife (16)
Date
Today (91)
Last 7 days (354)
Last 30 days (1898)
Last 365 days (31716)
2025 (17084)
2024 (35771)
2023 (40631)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32663)
2015 (38617)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (783)
Alabama (61)
Alaska (7)
Arizona (251)
Arkansas (14)
Asia (41118)
Australia (6569)
California (7485)
Canada (2377)
China (695)
Colorado (323)
Connecticut (320)
Delaware (195)
Europe (87855)
Florida (1125)
Georgia (248)
Hawaii (1)
Idaho (59)
Illinois (653)
India (28)
Indiana (370)
Iowa (16)
Japan (236)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1032)
Massachusetts (5605)
Michigan (248)
Minnesota (453)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (81)
New Hampshire (66)
New Jersey (2098)
New Mexico (29)
New York (2100)
North Carolina (1101)
North Dakota (8)
Northern California (3290)
Ohio (236)
Oklahoma (16)
Oregon (39)
Pennsylvania (1623)
Puerto Rico (17)
Rhode Island (36)
South America (1164)
South Carolina (35)
South Dakota (1)
Southern California (2799)
Tennessee (126)
Texas (1136)
United States (27855)
Utah (222)
Virginia (196)
Washington D.C. (72)
Washington State (641)
West Virginia (4)
Wisconsin (69)
724,749 Results for "oramed pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock - June 26, 2024
Oramed Pharmaceuticals Inc. announced today that its Board of Directors has authorized a common stock repurchase plan allowing for the buy-back of up to $20,000,000 in maximum value of its common stock through open market purchases, privately-negotiated transactions, or otherwise in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, over the next 12 months.
June 26, 2024
·
4 min read
Press Releases
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
April 29, 2025
·
6 min read
Pharm Country
Oramed Letter to Shareholders - June 26, 2024
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, issued a Letter to Shareholders from its Chief Executive Officer, Nadav Kidron.
June 26, 2024
·
7 min read
Press Releases
Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025
January 21, 2025
·
6 min read
Press Releases
UTILITY Therapeutics Announces Acquisition by Alembic Pharmaceuticals Inc.
July 3, 2025
·
7 min read
Press Releases
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
July 10, 2025
·
3 min read
Press Releases
Perre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for Tabelecleucel from Atara Biotherapeutics, Inc.
July 16, 2025
·
5 min read
Press Releases
Pierre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for Tabelecleucel from Atara Biotherapeutics, Inc.
July 16, 2025
·
5 min read
Press Releases
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
July 10, 2025
·
3 min read
Pharm Country
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company
Oramed Pharmaceuticals Inc. announced that on September 21, 2023, Oramed and Scilex Holding Company entered into a Securities Purchase Agreement pursuant to which Scilex issued a Senior Secured Promissory Note to Oramed.
September 21, 2023
·
6 min read
1 of 72,475
Next
